EDINBURGH LASER OPTICS LTD.

Financial Health Score: F

This grade reflects a state of chronic, severe insolvency. The company’s liabilities vastly exceed its assets, and it demonstrates no visible means of generating operational revenue. While the company is legally "Active," from a financial health perspective, it is on permanent life support.

1. Key Vital Signs

• Net Assets (Blood Pressure): £-356,666 — Critically low. A healthy company has positive net assets; a negative figure of this magnitude indicates that the company owes over £350,000 more than it owns. This is a chronic condition that has persisted and worsened over the last decade.
• Total Liabilities (Cholesterol): £358,631 — Dangerously high and accumulating. Liabilities have grown steadily year-over-year, acting as a heavy blockage restricting financial flow.
• Total Assets (Immune System): £1,965 — Dangerously low. With only £538 in current assets (cash or debtors) and £1,427 in fixed assets, the company has virtually no reserves to fight off financial shocks.
• Employees (Muscle Mass): 0 — The company reports zero employees, indicating it is not an operating trading entity but rather a shell or holding entity.

2. Diagnosis: Chronic Insolvency and Financial Hibernation

The financial data reveals a business that is technically insolvent. If a creditor were to call in the £358,631 debt, the company would immediately flatline, as it lacks the assets to pay even a fraction of what it owes.

However, looking at the "symptoms" more closely, this is likely a case of director-funded hibernation rather than a trading business in distress. Here is why:

• The "Life Support" Debt: With only £1,000 in share capital but over £350,000 in liabilities, it is almost certain that the vast majority of these liabilities are loans from the directors (Dr. Roger Hill and Kathleen Mary Hill) to the company. Because the directors own the debt, they will not force the company into liquidation to collect it.
• No Operational Pulse: The SIC codes (engineering consulting, technical testing, R&D) suggest a scientific or technical business, yet there are zero employees and virtually no current assets. This indicates the company is dormant or inactive, holding perhaps only intellectual property (the fixed assets) while accumulating ongoing administrative costs (like filing fees) that are paid for by the directors.
• Progressive Deterioration: The net liability position has worsened every single year since 2015. Like a slow-bleeding wound, the company leaks a little more equity each year into the red.

3. Prognosis: Guarded but Stable (Under Current Ownership)

The future outlook for this company depends entirely on the intentions of Dr. Roger Hill (the Person with Significant Control who owns over 75% of the shares):

• If the goal is to maintain the status quo: The company can survive indefinitely in this vegetative state. As long as the directors are willing to continue funding the minimal costs (and not demanding loan repayment), the company will not die. However, it will remain financially "brain dead"—unable to secure credit, attract investors, or operate commercially.
• If the goal is commercialization: The current financial structure is fatal to outside investment. No investor will put money into a company with a £350k deficit, as their money would simply vanish into the debt hole.
• If the directors withdraw support: Immediate cessation of business (Liquidation).

4. Recommendations: Prescribing a Path to Wellness

To improve this financial condition, the following actions should be considered:

1. Surgical Debt Restructuring (Capitalization of Director Loans): If the directors wish to revive the company for commercial use, they should formally convert a portion of their director loans into share capital. This would instantly improve the net asset position, bringing the "blood pressure" back to a healthier, positive reading and making the company legally solvent.
2. Euthanasia by Choice (Voluntary Strike-Off): If the R&D or intellectual property held by the company is no longer being actively developed, the most financially sound decision is to cease operations. The directors should apply to have the company struck off the register. The £1,427 in fixed assets can be distributed, and the remaining director loan debt can be written off personally, stopping the annual financial bleed.
3. Asset Transplant: If there is valuable intellectual property (patents, designs) within the company, it should be transferred to a new, healthy corporate entity with clean finances before this company is closed. Starting fresh with zero liabilities is far healthier than trying to resuscitate a body with £350k of debt.